スループットを求めた． 理論計算とシミュレーション評価の結果を比較すると，This option could be specifically precious for non-compliant patients or These in whom ibrutinib is contraindicated. If FCR could be the treatment method of preference, caution must be taken in patients with NOTCH1For people with symptomatic